Since Nos2 inhibitors were previously shown not to have an effect on macrophage killing in vitro [3], it is likely that the absence of nitric oxide will only affect neutrophil killing activity during the primary SR/CR response to cancer in vivo. Here, NOS2 is linked to cancer.